Lung carcinogenesis: Chemoprevention by Indole-3-carbinol

肺癌发生:3-吲哚甲醇的化学预防

基本信息

  • 批准号:
    7762766
  • 负责人:
  • 金额:
    $ 25.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-02-01 至 2013-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Lung cancer is the most common cause of cancer death worldwide. About 90% of all lung cancers are directly attributable to smoking. Despite considerable efforts in reducing the prevalence of tobacco use in the U.S., over 45 million adult Americans are still smokers. Former smokers are also at a high risk of lung cancer. One promising alternative approach to reduce lung cancer mortality is the use of chemopreventive agents. Currently, there is not any effective cancer chemopreventive agent for human use. Our long-term goal is to develop effective lung cancer chemopreventive agents which can inhibit lung cancer in current and former smokers. We propose that indole-3-carbinol (I3C), a constituent of Brassica vegetables, inhibits 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels. NNK is highly implicated in tobacco-induced lung cancer in smokers. Our hypothesis is based on (1) Epidemiologic studies which indicate an inverse association between high consumption of Brassica vegetables and the incidence of lung cancer; (2) The high concentration of indole glucosinolates, the parent compounds for I3C, in Brassica vegetables; (3) Cancer preventive activity of I3C in in vitro and in vivo lung cancer models; and (4) modulation by I3C of tumorigenesis-related genes/proteins. Our aims in this proposal are: (1) Test the chemopreventive efficacy of I3C against NNK-induced lung tumorigenesis in A/J mice. Mice will be treated with NNK and given I3C at different temporal sequences, or for different durations of time, lungs harvested and incidence and multiplicity of macroscopic and microscopic tumors determined. (2) Identify differentially expressed proteins in type II pneumocytes, the cells from which lung adenoma arise, of NNK-, NNK plus I3C, or I3C-treated A/J mice. For this, we will use relative and absolute quantitation (iTRAQ) proteomics technology and antibody-based protein microarray. (3) Identify, using antibody-based protein microarray approach, differential proteomic patterns in the serum and bronchoalveolar lavage fluid (BALF) of mice treated with NNK, I3C, or NNK and I3C and assess functional consequences of alterations in protein levels. Overall, the results of this project will provide a solid platform for clinical trials of I3C as a chemopreventive agent against lung cancer. PUBLIC HEALTH RELEVANCE: The failure of standard approaches, smoking prevention and cessation efforts, treatment and screening, to reduce lung cancer mortality motivated an interest in chemoprevention. At present, no effective chemopreventive agent is available for human. Proving the hypothesis that indole-3-carbinol (I3C) inhibits lung tumorigenesis in A/J mouse model provides a solid platform for clinical trials of I3C as a chemopreventive agent against lung cancer.
描述(由申请人提供):肺癌是全球癌症死亡的最常见原因。大约90%的肺癌直接归因于吸烟。尽管在减少美国烟草使用的流行方面做出了相当大的努力,超过4500万美国成年人仍然吸烟。前吸烟者患肺癌的风险也很高。降低肺癌死亡率的一种有希望的替代方法是使用化学预防剂。目前,没有任何有效的癌症化学预防剂用于人类使用。我们的长期目标是开发有效的肺癌化学预防剂,可以抑制目前和以前吸烟者的肺癌。我们提出,吲哚-3-甲醇(I3 C),芸苔属蔬菜的成分,抑制4-(甲基亚硝胺)-1-(3-吡啶基)-1-丁酮(NNK)诱导的A/J小鼠肺肿瘤的发生和调节致癌物诱导的蛋白质水平的变化。NNK与吸烟者中烟草诱导的肺癌高度相关。我们的假设是基于(1)流行病学研究表明大量食用芸苔属蔬菜与肺癌发病率呈负相关;(2)芸苔属蔬菜中高浓度的吲哚硫代葡萄糖甙(I3 C的母体化合物);(3)I3 C在体外和体内肺癌模型中的癌症预防活性;(4)I3 C在体内和体外肺癌模型中的癌症预防活性。(4)I3 C对肿瘤发生相关基因/蛋白的调节。本研究的目的是:(1)检测I3 C对NNK诱导的A/J小鼠肺肿瘤发生的化学预防作用。将用NNK处理小鼠并以不同的时间顺序或不同的持续时间给予I3 C,收获肺并确定肉眼和显微镜下肿瘤的发生率和多样性。(2)鉴定NNK-、NNK + I3 C或I3 C处理的A/J小鼠II型肺细胞(肺腺瘤产生的细胞)中差异表达的蛋白质。为此,我们将使用相对和绝对定量(iTRAQ)蛋白质组学技术和基于抗体的蛋白质微阵列。(3)使用基于抗体的蛋白质微阵列方法鉴定用NNK、I3 C或NNK和I3 C处理的小鼠的血清和支气管肺泡灌洗液(BALF)中的差异蛋白质组学模式,并评估蛋白质水平改变的功能后果。总体而言,该项目的结果将为I3 C作为肺癌化学预防剂的临床试验提供坚实的平台。公共卫生关系:标准方法、吸烟预防和戒烟努力、治疗和筛查在降低肺癌死亡率方面的失败激发了人们对化学预防的兴趣。目前,尚无有效的化学预防剂。吲哚-3-甲醇(indole-3-carbinol,I3 C)抑制A/J小鼠肺肿瘤发生的假说的证实为I3 C作为肺癌化学预防剂的临床试验提供了坚实的平台。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Fekadu Kassie其他文献

Fekadu Kassie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Fekadu Kassie', 18)}}的其他基金

Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells
通过靶向表达 ALDH1 和 CD44 的假定肺癌干细胞来预防和治疗肺癌
  • 批准号:
    10478169
  • 财政年份:
    2019
  • 资助金额:
    $ 25.07万
  • 项目类别:
Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells
通过靶向表达 ALDH1 和 CD44 的假定肺癌干细胞来预防和治疗肺癌
  • 批准号:
    10227075
  • 财政年份:
    2019
  • 资助金额:
    $ 25.07万
  • 项目类别:
Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells
通过靶向表达 ALDH1 和 CD44 的假定肺癌干细胞来预防和治疗肺癌
  • 批准号:
    10019474
  • 财政年份:
    2019
  • 资助金额:
    $ 25.07万
  • 项目类别:
Chemoprevention of inflammation-driven lung cancer
炎症驱动的肺癌的化学预防
  • 批准号:
    8435267
  • 财政年份:
    2013
  • 资助金额:
    $ 25.07万
  • 项目类别:
Chemoprevention of inflammation-driven lung cancer
炎症驱动的肺癌的化学预防
  • 批准号:
    8815111
  • 财政年份:
    2013
  • 资助金额:
    $ 25.07万
  • 项目类别:
Chemoprevention of inflammation-driven lung cancer
炎症驱动的肺癌的化学预防
  • 批准号:
    9016497
  • 财政年份:
    2013
  • 资助金额:
    $ 25.07万
  • 项目类别:
Diindolylmethane:Inhibition of lung squamous cell carcinoma by targeting Akt.
二吲哚基甲烷:通过靶向 Akt 抑制肺鳞状细胞癌。
  • 批准号:
    8383028
  • 财政年份:
    2012
  • 资助金额:
    $ 25.07万
  • 项目类别:
Diindolylmethane:Inhibition of lung squamous cell carcinoma by targeting Akt.
二吲哚基甲烷:通过靶向 Akt 抑制肺鳞状细胞癌。
  • 批准号:
    8510602
  • 财政年份:
    2012
  • 资助金额:
    $ 25.07万
  • 项目类别:
Lung carcinogenesis: Chemoprevention by Indole-3-carbinol
肺癌发生:3-吲哚甲醇的化学预防
  • 批准号:
    8010146
  • 财政年份:
    2009
  • 资助金额:
    $ 25.07万
  • 项目类别:
Lung carcinogenesis: Chemoprevention by Indole-3-carbinol
肺癌发生:3-吲哚甲醇的化学预防
  • 批准号:
    8409830
  • 财政年份:
    2009
  • 资助金额:
    $ 25.07万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 25.07万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 25.07万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 25.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 25.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 25.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 25.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 25.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 25.07万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 25.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 25.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了